Beta Bionics, Inc.
BBNX
$10.20
$0.303.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 56.62% | 57.15% | 63.14% | 54.45% | 36.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.62% | 57.15% | 63.14% | 54.45% | 36.39% |
| Cost of Revenue | 29.08% | 50.58% | 55.74% | 54.19% | 51.22% |
| Gross Profit | 83.22% | 62.07% | 69.61% | 54.66% | 24.58% |
| SG&A Expenses | 51.59% | 60.76% | 62.49% | 73.86% | 79.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.04% | 44.11% | 60.02% | 60.68% | 62.07% |
| Operating Income | -30.20% | -23.68% | -55.26% | -68.64% | -97.21% |
| Income Before Tax | 23.59% | 25.64% | -45.94% | -16.64% | -130.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.59% | 25.64% | -45.94% | -16.64% | -130.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.59% | 25.64% | -45.94% | -16.64% | -130.19% |
| EBIT | -30.20% | -23.68% | -55.26% | -68.64% | -97.21% |
| EBITDA | -29.16% | -21.72% | -56.50% | -70.00% | -100.08% |
| EPS Basic | 47.19% | 88.78% | 77.73% | 83.59% | 54.87% |
| Normalized Basic EPS | 47.18% | 88.79% | 77.73% | 83.59% | 54.87% |
| EPS Diluted | 47.19% | 88.78% | 77.73% | 83.59% | 54.87% |
| Normalized Diluted EPS | 47.18% | 88.79% | 77.73% | 83.59% | 54.87% |
| Average Basic Shares Outstanding | 44.67% | 563.02% | 555.12% | 610.65% | 410.05% |
| Average Diluted Shares Outstanding | 44.67% | 563.02% | 555.12% | 610.65% | 410.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |